体检人群中子宫肌瘤患者的脉象图与脉波图的研究
|
摘要
1目的
理论研究：比较脉象仪和脉波仪分析脉搏波的方法,发现两者的异同。
临床研究：对子宫肌瘤组与非子宫肌瘤组的脉象、脉形、脉象图参数、脉波图参数、以及中医体质分布情况进行研究,探讨子宫肌瘤患者的脉象、脉形、脉象图参数、脉波图参数的特征,以及上述指标与体质的相关性,并为子宫肌瘤患者的体质调理提供脉诊依据。
2方法
研究对象为健康体检人群中的子宫肌瘤患者,采用病例对照的原则收集样本。以《中医体质问卷》的调查结果为依据,确定研究对象的体质类型。采集研究对象的脉象图和脉波图；分析脉象仪自动诊断的脉象；运用统计软件对所获得的脉象图、脉波图参数进行数据分析。
3结果
3.1理论研究
通过对脉象仪和脉波仪的工作原理、分析方法和特征参数等进行分析比较,发现两者的异同。脉象仪是在中医脉象诊断的基础上,主要根据脉象的位、数、形、势确定所分析的参数,并在此基础上评价参数的意义,脉象的分析结果用于反映全身的整体状态。脉波仪是建立在西医物理学、解剖学的基础上,从心血管功能的角度来确定分析参数和评价参数的意义,脉搏波的分析结果主要用来评估循环系统的功能状态。
3.2临床研究一
子宫肌瘤患者的脉象图与脉波图的参数分析
3.2.1子宫肌瘤患者的脉象分布特点
根据脉象仪自动进行的脉名诊断,子宫肌瘤组与非子宫肌瘤组的脉象分布没有统计学差异,弦脉类脉象均占70%以上。弦脉无力是子宫肌瘤组各类复合脉中出现率最高的脉象。子宫肌瘤组的平弦脉和滑脉类脉象的出现率高于非子宫肌瘤组；子宫肌瘤组的弦缓脉、伏脉出现率低于非子宫肌瘤组。
3.2.2子宫肌瘤患者脉象的脉形分布特征
子宫肌瘤组与非子宫肌瘤组的脉形分布有统计学差异,表现为子宫肌瘤组abc脉形的出现率高于非子宫肌瘤组。
3.2.3子宫肌瘤患者的脉象图参数与脉波图参数的特征
子宫肌瘤组与非子宫肌瘤组的脉象图、脉波图参数比较有统计学差异。表现为子宫肌瘤组的h4、Ad、最佳压力、h4/h1、rAI、rAP的均值小于非子宫肌瘤组；h5、h5/h1的均值大于非子宫肌瘤组。
3.3临床研究二
不同体质的子宫肌瘤患者的脉象图与脉波图的参数分析
3.3.1子宫肌瘤组与非子官肌瘤组的体质及脉象分布特征
子宫肌瘤组与非子宫肌瘤组的体质分布有统计学差异。实性体质、特别是痰湿质在子宫肌瘤组中的出现率明显高于非子宫肌瘤组。子宫肌瘤组与非子宫肌瘤组的不同体质者的脉象分布无统计学差异。
3.3.2不同体质的脉象图参数与脉波图参数的特征
子宫肌瘤组中9种不同体质组的脉象图参数与脉波图参数比较具有统计学差异。特禀质组的脉率均值最大,气郁质组的脉率均值最小；痰湿质组的SBP、CASP的均值最大、湿热质组的SBP、CASP的均值最小。
子宫肌瘤组的平和质组、虚性体质组、实性体质组的脉象图参数与脉波图参数比较具有统计学差异。脉率均值从大到小的排列顺序为：虚性体质组>实性体质组>平和质组。t均值排列顺序则正好相反。DBP均值从大到小的排列顺序为平和质组>实性体质组>虚性体质组。PR均值从大到小的排列顺序为虚性体质组>平和质组>实性体质组；rAI和rAP的均值从大到小的排列顺序都为实性体质组>平和质组>虚性体质组。
比较子宫肌瘤患者的平和质组和阳虚质组的脉象图参数、脉波图参数。平和质组的SBP、DBP、MAP1、MAP2、CASP的均值大于阳虚质组；h4、h5、h5/h1、A/t、PR均值小于阳虚质组。
3.3.3同体质的子宫肌瘤组与非子宫肌瘤组的脉象图参数与脉波图参数比较
对子宫肌瘤组与非子宫肌瘤组中属同一体质类型的受试者的脉象图参数与脉波图参数进行比较,提示平和质组、阳虚质组、阴虚质组、气虚质组、湿热质组和痰湿质组的脉象图参数或脉波图参数具有统计学差异。
4结语
(1)脉象图与脉波图分析的理论基础不同,但测量的主要参数具有相似性。以子宫肌瘤的病例对照研究为例,所获得的脉象图和脉波图参数多表现为相同的倾向。
(2)子宫肌瘤组的脉象图参数h1均值和脉波图参数PP均值、脉象图参数h3/h1均值和脉波图参数rAI均值均小于非子宫肌瘤组,其中两组rAI均值的比较有统计学差异。子宫肌瘤组的脉象图参数脉率均值和脉波图参数PR均值大于非子宫肌瘤组。
(3)脉形、脉象图参数、脉波图参数的比较结果表明：与非子宫肌瘤组比较,子宫肌瘤组的血管弹性、顺应性增加、血管外周阻力减小
(4)实性体质者、特别是痰湿质者患子宫肌瘤的几率明显高于平和质者和其它体质者。
(5)子宫肌瘤患者的特禀质组脉率增快；虚性体质组的脉率也增快,特别是阳虚质组的脉率。
(6)“痰湿”可以导致子宫肌瘤患者的SBP、CASP升高。与平和质组、实性体质组相比,子宫肌瘤患者虚性体质组的心脏收缩功能减弱；血管顺应性升高。
(7)比较同体质类型的子宫肌瘤组与非子宫肌瘤组的脉象图参数与脉波图参数,发现平和质、阳虚质、阴虚质、气虚质、痰湿质、湿热质的子宫肌瘤组与非子宫肌瘤组的脉象图参数或脉波图参数存在差异。
1 Objective
Theoretical Study: To compare the analysis methods of pulse diagnosis analytical instrument and pulse wave analytical instrument, finding the similarities and differences between them. Clinic Research: To study the pulse manifestation, pulse shape, pulse manifestation graph parameters, pulse wave graph parameters, and TCM constitution of uterine fibroids group and non-uterine fibroids group. Getting the characteristics of them and the correlation between the pulse manifestation graph parameters、pulse wave graph parameters and TCM constitution, provide pulse diagnosis reference to TCM constitution conditions for uterine fibroids patients.
2 Methods
The subjects were healthy checking people, collecting samples using case-control principle. Accord to the result of "Questionnaire about constitution of TCM ", define the constitution type of the subjects. Collecting and analyzing the pulse manifestation graph and pulse wave graph, and obtaining the information of the parameters of them. Analyze the data using statistical software.
3 Results
3.1 Theoretical Study
To comparing the work principle and analysis method of the two instruments, and finding out the similarities and differences between them. Pulse diagnosis analytical instrument is built on the basis of pulse manifestation, and the parameters related to "Position. Pulse rate. Shape and Situation". On this basis, we evaluate the significance of parameters. The analysis results of pulse manifestation can reflect the overall state of the whole body. Pulse wave analytical instrument is built on the basis of physics and anatomy, from the perspective of cardiovascular function, to determine the significance of analyzing and evaluating the parameters.The analysis results is mainly used to assess the functional status of the circulatory system.
3.2 Clinic Research One
To analyze the parameters'characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients.
3.2.1 The pulse manifestation distribution characteristics of the uterine fibroids patients
According to the name of pulse manifestation which the Pulse diagnosis analytical instrument gives automatically, and there isn't statistically significant about pulse manifestation distribution between the uterine fibroids group and the non-uterine fibroids group, and all kinds of wiry pulse account for more than 70%. The occurrence of weak-wiry pulse in the uterine fibroids group is the highest. But the occurrence of moral wiry pulse and slippery pulse sorts in the uterine fibroids group is higher than in the non-uterine fibroids group; the occurrence of wiry-moderate pulse and hidden pulse in the uterine fibroids group is lower than in the non-uterine fibroids group.
3.2.2 The pulse shape distribution characteristics of the uterine fibroids patients
There is statistically pulse shape significant between the uterine fibroids group and the non-uterine fibroids group. The difference is caused by abc-pulse shape. The occurrence of abc-pulse shape is higher in the uterine fibroids group.
3.2.3 The parameters' characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients
There is statistically significant about the parameters of pulse manifestation graph and pulse wave graph between the uterine fibroids group and the non-uterine fibroids group. The mean of h4、Ad、“最佳压力”、h4/h1、rAI、rAP is lower in the uterine fibroids group; the mean of h5、h5/h1 is higher in the uterine fibroids group.
3.3 Clinic Research two
Research on the parameters' characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients who have the different constitution
3.3.1 The constitution and pulse manifestation distribution characteristics of the uterine fibroids group and the non-uterine fibroids group
There is statistically constitution significant between the uterine fibroids group and the non-uterine fibroids group. The occurrence of phlegm-dampness constitution and excess constitution is higher in the uterine fibroids group. There isn't statistically significant in pulse manifestation distribution between the two groups.
3.3.2 The parameters' characteristics of pulse manifestation graph and pulse wave graph in people who have different constitution
There is statistically significant in the parameters of pulse manifestation graph and pulse wave graph in 9 kinds of constitution. The mean of pulse rate is the highest in special diathesis constitution group, and the Qi depression constitution group's is the lowest. The mean of SBP and CASP is the highest in phlegm-dampness constitution group, and dampness-heat constitution group's is the lowest.
There is statistically significant in the parameters' characteristics of pulse manifestation graph and pulse wave graph in gentleness constitution group、deficiency constitution group and excess constitution group. The order of rate mean from the highest to the lowest is deficiency constitution group> excess constitution group> gentleness constitution group. The order of t mean is opposite. The order of DBP mean from the highest to the lowest is gentleness constitution group> excess constitution group> deficiency constitution group. The order of PR mean from the highest to the lowest is deficiency constitution group> gentleness constitution group> excess constitution group. The order of rAI mean and rAP mean from the highest to the lowest is excess constitution group> gentleness constitution group> deficiency constitution group.
To compare the parameters of pulse manifestation graph and pulse wave graph in gentleness constitution group and Yang deficiency constitution group. The mean of SBP、DBP、MAP1、MAP2、CASP in gentleness constitution group is higher than in Yang deficiency constitution group. The mean of h4、h5、h5/h1、A/t、PR in gentleness constitution group is lower than in Yang deficiency constitution group.
3.3.4 The parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution
To compare the parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution, we find that there is statistically significant in the parameters' characteristics of pulse manifestation graph or pulse wave graph in gentleness constitution group、Yin deficiency constitution group、Yang deficiency constitution group Qi deficiency constitution group、dampness-heat constitution group and phlegm-dampness constitution group.
4 Conclusions
(1) The theoretical basis of pulse manifestation graph and pulse wave graph is different, but the main parameters measured are similar. In the case-control study of uterine fibroids, the pulse manifestation graph parameters and pulse wave graph parameters show the same tendency.
(2)The pulse manifestation graph parameters h1、h3/hland pulse wave graph parameters PP、rAI of the uterine fibroids patients are lower,and the mean of rAI has statistically significantm in the two groups. The pulse manifestation graph parameters"脉率"and pulse wave graph parameters PR of the uterine fibroids patients group are higher.
(3)To compare the pulse shape、the parameters of pulse manifestation graph and pulse wave graph in people, the result shows that the artery flexibility and the artery compliance increased, and the artery peripheral resistance decreased.
(4) The excess constitution group is susceptible to have uterine fibroids, especially phlegm-dampness constitution.
(5) The mean of pulse rate is the highest in special diathesis constitution group, and deficiency constitution group's pulse rate is faster, especially Qi deficiency.
(6) Phlegm-dampness constitution cause SBP, CASP's increase. The deficiency constitution group'systolic function reduce, and vascular compliance increased.
(7) To compare the parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution, and we find that the difference is caused by gentleness constitution、Yang deficiency constitution、Qi deficiency constitution、dampness-heat constitution and phlegm-dampness constitution.
理论研究：比较脉象仪和脉波仪分析脉搏波的方法,发现两者的异同。
临床研究：对子宫肌瘤组与非子宫肌瘤组的脉象、脉形、脉象图参数、脉波图参数、以及中医体质分布情况进行研究,探讨子宫肌瘤患者的脉象、脉形、脉象图参数、脉波图参数的特征,以及上述指标与体质的相关性,并为子宫肌瘤患者的体质调理提供脉诊依据。
2方法
研究对象为健康体检人群中的子宫肌瘤患者,采用病例对照的原则收集样本。以《中医体质问卷》的调查结果为依据,确定研究对象的体质类型。采集研究对象的脉象图和脉波图；分析脉象仪自动诊断的脉象；运用统计软件对所获得的脉象图、脉波图参数进行数据分析。
3结果
3.1理论研究
通过对脉象仪和脉波仪的工作原理、分析方法和特征参数等进行分析比较,发现两者的异同。脉象仪是在中医脉象诊断的基础上,主要根据脉象的位、数、形、势确定所分析的参数,并在此基础上评价参数的意义,脉象的分析结果用于反映全身的整体状态。脉波仪是建立在西医物理学、解剖学的基础上,从心血管功能的角度来确定分析参数和评价参数的意义,脉搏波的分析结果主要用来评估循环系统的功能状态。
3.2临床研究一
子宫肌瘤患者的脉象图与脉波图的参数分析
3.2.1子宫肌瘤患者的脉象分布特点
根据脉象仪自动进行的脉名诊断,子宫肌瘤组与非子宫肌瘤组的脉象分布没有统计学差异,弦脉类脉象均占70%以上。弦脉无力是子宫肌瘤组各类复合脉中出现率最高的脉象。子宫肌瘤组的平弦脉和滑脉类脉象的出现率高于非子宫肌瘤组；子宫肌瘤组的弦缓脉、伏脉出现率低于非子宫肌瘤组。
3.2.2子宫肌瘤患者脉象的脉形分布特征
子宫肌瘤组与非子宫肌瘤组的脉形分布有统计学差异,表现为子宫肌瘤组abc脉形的出现率高于非子宫肌瘤组。
3.2.3子宫肌瘤患者的脉象图参数与脉波图参数的特征
子宫肌瘤组与非子宫肌瘤组的脉象图、脉波图参数比较有统计学差异。表现为子宫肌瘤组的h4、Ad、最佳压力、h4/h1、rAI、rAP的均值小于非子宫肌瘤组；h5、h5/h1的均值大于非子宫肌瘤组。
3.3临床研究二
不同体质的子宫肌瘤患者的脉象图与脉波图的参数分析
3.3.1子宫肌瘤组与非子官肌瘤组的体质及脉象分布特征
子宫肌瘤组与非子宫肌瘤组的体质分布有统计学差异。实性体质、特别是痰湿质在子宫肌瘤组中的出现率明显高于非子宫肌瘤组。子宫肌瘤组与非子宫肌瘤组的不同体质者的脉象分布无统计学差异。
3.3.2不同体质的脉象图参数与脉波图参数的特征
子宫肌瘤组中9种不同体质组的脉象图参数与脉波图参数比较具有统计学差异。特禀质组的脉率均值最大,气郁质组的脉率均值最小；痰湿质组的SBP、CASP的均值最大、湿热质组的SBP、CASP的均值最小。
子宫肌瘤组的平和质组、虚性体质组、实性体质组的脉象图参数与脉波图参数比较具有统计学差异。脉率均值从大到小的排列顺序为：虚性体质组>实性体质组>平和质组。t均值排列顺序则正好相反。DBP均值从大到小的排列顺序为平和质组>实性体质组>虚性体质组。PR均值从大到小的排列顺序为虚性体质组>平和质组>实性体质组；rAI和rAP的均值从大到小的排列顺序都为实性体质组>平和质组>虚性体质组。
比较子宫肌瘤患者的平和质组和阳虚质组的脉象图参数、脉波图参数。平和质组的SBP、DBP、MAP1、MAP2、CASP的均值大于阳虚质组；h4、h5、h5/h1、A/t、PR均值小于阳虚质组。
3.3.3同体质的子宫肌瘤组与非子宫肌瘤组的脉象图参数与脉波图参数比较
对子宫肌瘤组与非子宫肌瘤组中属同一体质类型的受试者的脉象图参数与脉波图参数进行比较,提示平和质组、阳虚质组、阴虚质组、气虚质组、湿热质组和痰湿质组的脉象图参数或脉波图参数具有统计学差异。
4结语
(1)脉象图与脉波图分析的理论基础不同,但测量的主要参数具有相似性。以子宫肌瘤的病例对照研究为例,所获得的脉象图和脉波图参数多表现为相同的倾向。
(2)子宫肌瘤组的脉象图参数h1均值和脉波图参数PP均值、脉象图参数h3/h1均值和脉波图参数rAI均值均小于非子宫肌瘤组,其中两组rAI均值的比较有统计学差异。子宫肌瘤组的脉象图参数脉率均值和脉波图参数PR均值大于非子宫肌瘤组。
(3)脉形、脉象图参数、脉波图参数的比较结果表明：与非子宫肌瘤组比较,子宫肌瘤组的血管弹性、顺应性增加、血管外周阻力减小
(4)实性体质者、特别是痰湿质者患子宫肌瘤的几率明显高于平和质者和其它体质者。
(5)子宫肌瘤患者的特禀质组脉率增快；虚性体质组的脉率也增快,特别是阳虚质组的脉率。
(6)“痰湿”可以导致子宫肌瘤患者的SBP、CASP升高。与平和质组、实性体质组相比,子宫肌瘤患者虚性体质组的心脏收缩功能减弱；血管顺应性升高。
(7)比较同体质类型的子宫肌瘤组与非子宫肌瘤组的脉象图参数与脉波图参数,发现平和质、阳虚质、阴虚质、气虚质、痰湿质、湿热质的子宫肌瘤组与非子宫肌瘤组的脉象图参数或脉波图参数存在差异。
1 Objective
Theoretical Study: To compare the analysis methods of pulse diagnosis analytical instrument and pulse wave analytical instrument, finding the similarities and differences between them. Clinic Research: To study the pulse manifestation, pulse shape, pulse manifestation graph parameters, pulse wave graph parameters, and TCM constitution of uterine fibroids group and non-uterine fibroids group. Getting the characteristics of them and the correlation between the pulse manifestation graph parameters、pulse wave graph parameters and TCM constitution, provide pulse diagnosis reference to TCM constitution conditions for uterine fibroids patients.
2 Methods
The subjects were healthy checking people, collecting samples using case-control principle. Accord to the result of "Questionnaire about constitution of TCM ", define the constitution type of the subjects. Collecting and analyzing the pulse manifestation graph and pulse wave graph, and obtaining the information of the parameters of them. Analyze the data using statistical software.
3 Results
3.1 Theoretical Study
To comparing the work principle and analysis method of the two instruments, and finding out the similarities and differences between them. Pulse diagnosis analytical instrument is built on the basis of pulse manifestation, and the parameters related to "Position. Pulse rate. Shape and Situation". On this basis, we evaluate the significance of parameters. The analysis results of pulse manifestation can reflect the overall state of the whole body. Pulse wave analytical instrument is built on the basis of physics and anatomy, from the perspective of cardiovascular function, to determine the significance of analyzing and evaluating the parameters.The analysis results is mainly used to assess the functional status of the circulatory system.
3.2 Clinic Research One
To analyze the parameters'characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients.
3.2.1 The pulse manifestation distribution characteristics of the uterine fibroids patients
According to the name of pulse manifestation which the Pulse diagnosis analytical instrument gives automatically, and there isn't statistically significant about pulse manifestation distribution between the uterine fibroids group and the non-uterine fibroids group, and all kinds of wiry pulse account for more than 70%. The occurrence of weak-wiry pulse in the uterine fibroids group is the highest. But the occurrence of moral wiry pulse and slippery pulse sorts in the uterine fibroids group is higher than in the non-uterine fibroids group; the occurrence of wiry-moderate pulse and hidden pulse in the uterine fibroids group is lower than in the non-uterine fibroids group.
3.2.2 The pulse shape distribution characteristics of the uterine fibroids patients
There is statistically pulse shape significant between the uterine fibroids group and the non-uterine fibroids group. The difference is caused by abc-pulse shape. The occurrence of abc-pulse shape is higher in the uterine fibroids group.
3.2.3 The parameters' characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients
There is statistically significant about the parameters of pulse manifestation graph and pulse wave graph between the uterine fibroids group and the non-uterine fibroids group. The mean of h4、Ad、“最佳压力”、h4/h1、rAI、rAP is lower in the uterine fibroids group; the mean of h5、h5/h1 is higher in the uterine fibroids group.
3.3 Clinic Research two
Research on the parameters' characteristics of pulse manifestation graph and pulse wave graph in uterine fibroids patients who have the different constitution
3.3.1 The constitution and pulse manifestation distribution characteristics of the uterine fibroids group and the non-uterine fibroids group
There is statistically constitution significant between the uterine fibroids group and the non-uterine fibroids group. The occurrence of phlegm-dampness constitution and excess constitution is higher in the uterine fibroids group. There isn't statistically significant in pulse manifestation distribution between the two groups.
3.3.2 The parameters' characteristics of pulse manifestation graph and pulse wave graph in people who have different constitution
There is statistically significant in the parameters of pulse manifestation graph and pulse wave graph in 9 kinds of constitution. The mean of pulse rate is the highest in special diathesis constitution group, and the Qi depression constitution group's is the lowest. The mean of SBP and CASP is the highest in phlegm-dampness constitution group, and dampness-heat constitution group's is the lowest.
There is statistically significant in the parameters' characteristics of pulse manifestation graph and pulse wave graph in gentleness constitution group、deficiency constitution group and excess constitution group. The order of rate mean from the highest to the lowest is deficiency constitution group> excess constitution group> gentleness constitution group. The order of t mean is opposite. The order of DBP mean from the highest to the lowest is gentleness constitution group> excess constitution group> deficiency constitution group. The order of PR mean from the highest to the lowest is deficiency constitution group> gentleness constitution group> excess constitution group. The order of rAI mean and rAP mean from the highest to the lowest is excess constitution group> gentleness constitution group> deficiency constitution group.
To compare the parameters of pulse manifestation graph and pulse wave graph in gentleness constitution group and Yang deficiency constitution group. The mean of SBP、DBP、MAP1、MAP2、CASP in gentleness constitution group is higher than in Yang deficiency constitution group. The mean of h4、h5、h5/h1、A/t、PR in gentleness constitution group is lower than in Yang deficiency constitution group.
3.3.4 The parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution
To compare the parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution, we find that there is statistically significant in the parameters' characteristics of pulse manifestation graph or pulse wave graph in gentleness constitution group、Yin deficiency constitution group、Yang deficiency constitution group Qi deficiency constitution group、dampness-heat constitution group and phlegm-dampness constitution group.
4 Conclusions
(1) The theoretical basis of pulse manifestation graph and pulse wave graph is different, but the main parameters measured are similar. In the case-control study of uterine fibroids, the pulse manifestation graph parameters and pulse wave graph parameters show the same tendency.
(2)The pulse manifestation graph parameters h1、h3/hland pulse wave graph parameters PP、rAI of the uterine fibroids patients are lower,and the mean of rAI has statistically significantm in the two groups. The pulse manifestation graph parameters"脉率"and pulse wave graph parameters PR of the uterine fibroids patients group are higher.
(3)To compare the pulse shape、the parameters of pulse manifestation graph and pulse wave graph in people, the result shows that the artery flexibility and the artery compliance increased, and the artery peripheral resistance decreased.
(4) The excess constitution group is susceptible to have uterine fibroids, especially phlegm-dampness constitution.
(5) The mean of pulse rate is the highest in special diathesis constitution group, and deficiency constitution group's pulse rate is faster, especially Qi deficiency.
(6) Phlegm-dampness constitution cause SBP, CASP's increase. The deficiency constitution group'systolic function reduce, and vascular compliance increased.
(7) To compare the parameters of pulse manifestation graph and pulse wave graph in people who have the same constitution, and we find that the difference is caused by gentleness constitution、Yang deficiency constitution、Qi deficiency constitution、dampness-heat constitution and phlegm-dampness constitution.
引文
[1]田艳玲,闫学明.2001～2004年北京市西城区妇女病普查分析[J].中国妇幼保健，2008,23(4)：479-481
[2]刘秋梅,李荣,马娉,等.5910例已婚育龄妇女妇科普查及分析[J].当代医学,2008,(14)：48-49
[3]乐杰主编.妇产科学.(第四版)[M].北京：人民卫生出版社,1980.1：98-100
[4]罗元恺主编.中医妇科学.(第五版)[M].上海：上海科学技术出版社,1985.2：382-384
[5]马宝璋主编.中医妇科学(第六版)[M].上海：上海科技出版社,1997.6：217-220
[6]张玉珍.中医妇科学(第七版)[M].北京：中国中医药出版社,2002：309-312
[7]中华人民共和国卫生部.中药新药临床研究指导原则,1993,272-273.
[8]王娜梅,崔琳.马春芬教授治疗子宫肌瘤经验[J].中医研究,2007,20(2)：56-57
[9]张珍,梁如碧.加味桂枝茯苓丸治疗子宫肌瘤62例[J].陕西中医,2008,29(3)：273-274
[10]刘弘,经燕.辨证与辨病治疗子宫肌瘤[J].中日友好医院学报,2002,16(5-6)：349-350
[11]张玲.桂苓丸治疗子宫肌瘤60例[J].实用中医药杂志,2002,18(6)：18-19
[12]袁升平.逍遥散治验举偶[J].遵义医学院学报,2002,25(1)：75-77
[13]朱丽红,李世梅,邵文彬.杨家林教授论治子宫肌瘤的学术思想[J].中医研究,2002,15(1)：6-8
[14]齐聪钱,张勤华,黄宗瀚.补肾活血方治疗子宫肌瘤63例临床观察[J].四川中医,2003,21(5)：45-46
[15]李永琼.逍遥散加味治疗子宫肌瘤78例[J].四川中医,2003,21(12)：57
[16]马庆璋.桂枝茯苓丸加味治验3则[J].陕西中医,2003,24(5)：465
[17]张世友.经方治疗疑难病验案举隅[J].中国医药学报,2003,18(12)：735-736
[18]缪雪影.姬瘤散治疗子宫肌瘤280例[J].福建中医药,2003,34(6)：7-8
[19]郑楚云,钟启良.大黄蜇虫丸加味治疗子宫肌瘤60例[J].广西中医药,2003,26(5)：33
[20]李颖,秦淑芳,王丽娜.丹七化癥胶囊治疗子宫肌瘤临床观察[J].河南中医学院学报,2003,(3)：39-40
[21]吴文菊.紫草消瘤断经汤治疗围绝经期子宫肌瘤52例[J].浙江临床医学,2003,5(9)：687
[22]吴雪华.卵巢囊肿与子宫肌瘤治验[J].山西中医,2003,19(5)：56
[23]李冬华,何裕民.子宫肌瘤患者的证候分布规律研究[J].上海中医药大学学报,2003,17(2)：30-33
[24]马哲,段俊成,王丽芳.龙血竭胶囊治疗子宫肌瘤36例临床观察[J].临床医药实践杂志,2003,12(5)：376
[25]黄元英.子宫肌瘤中西药物治疗的研究现状及展望.[J].天津中医药,2003.12,20(6)：78-80
[26]李灵芝,李桂华,陈萍.散结消瘤汤治疗子宫肌瘤临床疗效观察[J].天津中医药,2003,20(5)：22-23
[27]姜萍,赵莹,阮跃龙,等.中西医结合治疗子宫肌瘤70例疗效观察[J].现代中西医结合杂志,2003,12(7)：707-708
[28]姜永,谢平生.中医药治疗子宫肌瘤186例[J].中国中医药信息杂志,2003,10(1)：44
[29]王刘英.桂枝茯苓胶囊治疗子宫肌瘤70例疗效观察[J].云南中医中药杂志,2003,24(2)：27
[30]马文侠,李翠萍.消瘤汤治疗子宫肌瘤42例[J].中医研究,2003,16(4)：43-44
[31]罗凌,朱亚萍.清宫瘤胶囊治疗子宫肌瘤110例[J].中国中医药科技,2003,10(6)：382-383
[32]孙淑芳,周琦,孙淑芳,等.中药内服外用治疗子宫肌瘤105例[J].贵州医药,2003,27(9)：862
[33]严英,周伟生,余琦.子宫肌瘤的中医治疗概况[J].新中医,2003,35(12)：62-64
[34]桑海莉.行气活血_软坚散结法治疗子宫肌瘤的临床与实验研究[J].中医杂志,2003,44(1)：41-43
[35]孙运美.自拟清宫化瘤散治疗子宫肌瘤20例疗效观察[J].现代中西医结合杂志,2004,13(2)：212
[36]盛晓波,赵强.牡蛎莪术汤治疗子宫肌瘤46例[J].浙江中医杂志2004,(3)：113
[37]王其蓉,魏书德.桂枝茯苓汤治疗子宫肌瘤13例[J].实用中医药杂志,2004,20(3)：124
[38]王燕兰.中西医结合治疗围绝经期子宫肌瘤64例疗效观察[J].吉林中医药,2004,25(1)：38-39
[39]戎海仁,于岗.活血化瘀法治疗妇科病拾零[J].河北中医,2004,26(3)：191-192
[40]高民.浅谈补气理气、活血化瘀治疗气滞血瘀型卵巢囊肿、子宫肌瘤的体会[J].黑龙江中医 药,2004,(2)：34-45
[41]曾菲英,刘文.肖承惊教授治疗子宫肌瘤经验述要[J].中医药学刊,2004,22(4)：587-588
[42]王福娟.桂枝茯苓丸临床应用[J].医案医话,2008,28(4)：290
[43]曾菲英.益气缩宫法治疗子宫肌瘤异常出血经验[J].北京中医药大学学报,2004,27(3)：91-92
[44]黄晓君.桂枝茯苓丸加味验案举隅[J].陕西中医,2004(5)：459-460
[45]邓德强,马骏.马德孚教授治疗癥瘕经验[J].河北中医,2004,26(4)：248-249
[46]王艳霞,赵友林.中药内服加灌肠治疗子宫肌瘤[J].实用中医内科杂志,2004,18(3)：258-259
[47]臧金霞.妇科化瘀胶囊临床使用总结报告[J].中医中药,2007,4(1)：115-116
[48]古春青.少腹逐瘀汤合大黄蛰虫丸加减治疗子宫肌瘤89例疗效观察[J].中医临床选萃,2007,23(22)：51
[49]王泽民,杜艳林,王婧.中医药治疗子宫肌瘤的进展[J].北京中医,2007,26(11)：752-754
[50]马露玲.消症汤保留灌肠治疗子宫肌瘤42例临床观察[J].临床医药实践杂志,2007,16(11)：1092-1093
[51]许雁.中西药联合治疗子宫肌瘤的效果观察[J].临床误诊误治,2007,20(7)：60-61
[52]钱麟,齐聪,张勤华.补肾消瘤方治疗80例子宫肌瘤临床疗效分析[J].实用诊断与治疗杂志,2007,21(8)：574-576
[53]马娴,傅萍.傅萍治疗子宫肌瘤临床经验[J].辽宁中医药大学学报,2007,9(5)：84-85
[54]刘向阳.胥受天老中医治疗子宫肌瘤经验简介[J].陕西中医,2001,22(6)：353
[55]肖笃凯.桂枝茯苓胶囊治疗子宫肌瘤308例疗效情况分析[J].中西医结合与祖国医学,2007,11(9)：793-794
[56]吕美.益气化瘀消瘤汤治疗子宫肌瘤60例临床观察[J].山东中医杂志,2007,26(9)：604-606
[57]张秋梅,陈旭,孙增玉,等.中药袁氏消瘤汤治疗子宫肌瘤临床观察[J].辽宁中医杂志,2007,34(9)：1272-1273
[58]招泽熙.中医辨证治疗子宫肌瘤39例[J].湖南中医药导报,1999,2(6)：13-14.
[59]李文红.中医辨证治疗子宫肌瘤38例[J].河北中医,2001,23(5)：337-338
[60]李天海,李橘梅,李瑞阳,等.子宫肌瘤的辨证分型治疗[J].河北中医,1999,20(5)：291-292.
[61]付静.桂枝茯苓丸化裁临床应用举隅[J].中国民间疗法,2007,15(7)：30-31
[62]孙永忠,金方.大黄牡丹汤妇科应用举隅[J].江西中医药,2007,38(6)：59
[63]马建军.自拟蛎甲散消汤治疗子宫肌瘤108例[J].实用中医内科杂志,2007,21(3)：40-41
[64]王佳禾.化癥丹治疗子宫肌瘤的临床研究[J].辽宁中医杂志,2007,34(6)：782-783
[65]黄丽慧.子宫肌瘤的中医药治疗近况[J].河北中医,2007,29(4)：363-365
[66]彭丽娜.疏肝消癥汤治疗子宫肌瘤50例临床体会[J].医疗保健器具,2007,(4)：13-14
[67]李晋先,张慧珍.中西医结合治疗子宫肌瘤疗效观察[J].长治医学院学报,2006,(4)：300-301
[68]张铁.血府逐瘀汤治疗血瘀气滞型子宫肌瘤的理论探析[J].中医药学刊,2006,24(10)：1928-1929
[69]张登山.王云铭辨治妇科症瘕经验[J].安徽中医学院学报,2006,25(4)：23-24
[70]武步涛.武明钦临床验案3则[J].河南中医,2006,26(8)：75
[71]杨玉杰.桃红四物汤加减治疗妇科病2例[J].辽宁中医杂志,2006,33(7)：863
[72]刘宪鸣.自拟消癥汤治疗子宫肌瘤53例[J].中国中医药科技,2006,13(2)：134-135
[73]高淑梅,刘会怡.益气活血法治疗子宫肌瘤40例疗效观察[J].实用中医内科杂志,2006,20(2)：190-191
[74]肖新春,傅金英.消瘋勿忘扶正[J].中医药学刊,2006,24(3)：492
[75]张秉芬,裴利红.自拟消瘤汤治疗子宫肌瘤80例[J].齐鲁护理杂志,2006,12(1)：83
[76]陆耘,邓志红.化癥汤治疗气滞血瘀证子宫肌瘤临床观察[J].安徽中医学院学报2005,24(6)：16-17
[77]安峥嵘.宫瘤汤治疗子宫肌瘤43例[J].现代中医药,2005,25(6)：30
[78]李祥云.中医妇科肿瘤的研究概况—李祥云教授妇科系列经验[J].辽宁中医杂志,2005,32(7)：636-638
[79]张健.化淤消癥汤治疗子宫肌瘤100例临床报告[J].中国自然医学杂志,2005,7(1)：71-72
[80]刘兴明.抵挡汤加味治疗子宫肌瘤28例[J].现代医药卫生,2005,21(9)：1118-1119
[81]孔洁,黄宝光.消肌汤治疗子宫肌瘤32例临床观察[J].吉林中医药,2005,25(1)：25
[82]肖颖,黄绳武.中药治疗子宫肌瘤的现代研究概况[J].广东医药,2005,15(1)：52-54
[83]张策.子宫肌瘤辨治心得[J].江苏中医药2005,(26)：22-23
[84]蒋薇.龙骨、牡蛎在妇科疾病中的应用[J].河北中医,2005,27(1)：34-35
[85]李凤军.中西医结合序贯治疗子宫肌瘤160例[J].河南中医,2005,25(1)：59-60
[86]冯泽芳.活血化滞消瘤汤内外兼治子宫肌瘤98例[J].四川中医,2005,23(2)：67
[87]李祥云.中医辨证与实验检查的研究—李祥云教授妇科系列经验[J].辽宁中医杂志,2005,32(1)：7-8
[88]林红.桂枝茯苓胶囊治疗妇科疾病临床效果分析[J].中国基层医药,2004,11(12)：1509
[89]王淑英.桂枝茯苓丸加味治疗妇人癥积[J].张家口医学院学报,2004,21(1)：67
[90]齐南,马彦超,周志刚.石瘕症治疗探讨[J].陕西中医学院学报,2004,27(6)：48-49
[91]杨会华.自拟方剂宫外孕Ⅱ号加减治疗子宫肌瘤60例[J].社区医学杂志,2004,2(1)：59-60
[92]吴阳平.消癥汤的临床应用[J].福建中医药,2004,35(5)：55
[93]刁莉.桂枝茯苓丸加味治疗子宫肌瘤[J].中国冶金工业医学杂志,2004,21(4)：317-318
[94]张志明,彭瑛.丁玉珠治疗疑难杂病举隅[J].内蒙古中医药,2002,(6)：15
[95]叶腾辉,陈敬康.宫瘤消胶囊治疗子宫肌瘤病60例[J].四川中医,2002,20(1)：53-54
[96]王玲,周益法.海藻玉壶汤临证举隅[J].深圳中西医结合杂志,1999,9(4)：46-47
[97]刘向阳.胥受天老中医治子宫肌瘤经验简介[J].陕西中医,2001,22(6)：353
[98]麦顺辉.子宫肌瘤86例中医辨证施治体会[J].广东医学,1999,20(3)：226
[99]韩惠兰,于飞.子宫肌瘤的中医治疗[J].中国实用妇科与产科杂志,2001,17(3)：135-136
[100]张新荣.当归芍药散合桂枝茯苓丸的临床新用[J].深圳中西医结合杂志,2001,11(3)：157-158
[101]爨昌劳,尚何青,富延萍.定经汤治疗子宫肌瘤30例[J].陕西中医,2002,23(11)：975-976
[102]张国恒,姚晓丽.扶正祛邪治疗子宫肌瘤36例分析[J].新疆中医药,2000,18(2)：19-20
[103]田敬然,马淑华.宫瘤消治疗子宫肌瘤100例疗效观察[J].河北中医,1999,21(5)：278
[104]刘乔平,何玉宁,郭红.桂枝茯苓丸加味治疗子宫肌瘤37例临床观察[J].云南中医中药杂志,2001,22(3)：35-36
[105]吴绣虹.桂枝茯苓丸配合活血化瘀药治疗子宫肌瘤37例[J].新中医,2001,33(8)：56-57
[106]耿静.海藻玉壶汤治疗妇科杂证举隅[J].深圳中西医结合杂志,2001,11(4)：237-238
[107]于涛,曹守伟,支楠.化湿散结汤治疗子宫平滑肌瘤30例疗效观察[J].江西中医 药,2002,33(5)：23-24
[108]任晓丹.李春华治疗子宫肌瘤经验[J].辽宁中医学院学报,2002,4(4)：291-292
[109]李云端.理冲汤治妇科癥瘕验案3则[J].国医论坛,2000,15(3)：37
[110]张丽君,刘华莎.通络消瘤汤治疗子宫肌瘤36例[J].安徽中医学院学报,2002,21(3)：22-23
[111]韩建锋.脱花煎加味治疗肿瘤[J],2002,(10)：437
[112]李乃荣.肖承宗益气化瘀祛痰法治疗子宫肌瘤经验[J].安徽中医临床杂志,2001,13(6)：455-456
[113]郭喜兰.血府逐瘀汤临床应用举隅[J].陕西中医,2002,23(8)：753
[114]陈芊.杨明亮治疗子宫肌瘤经验[J].江西中医药,2000,31(6)：6-7
[115]舒珊,舒畅.中西医结合治疗子宫肌瘤30例临床观察[J].洛阳医专学报,2001,19(4)：308-309
[116]李玲,何裕民,李冬华.中药“瘤净片”治疗子宫肌瘤78例疗效观察[J].上海中医药杂志,2000,(11)：24-25
[117]牛玉香.中医辨证施治子宫肌瘤20例报告[J].济宁医学院学报,1999,(2)：60
[118]那天佑,杨钟娣.子宫肌瘤106例治疗体会[J].云南中医中药杂志,2000,21(6)：9-11
[119]张晓.子宫肌瘤的病机及证治探讨[J].南京中医药大学学报,1999,15(3)：137-138
[120]杨家林.子宫肌瘤的中医治疗[J].实用妇产科杂志,1999,15(2)：66-67
[121]张成秀.自拟三山消癥汤治疗子宫肌瘤67例报告[J].甘肃中医,2002,15(3)：53
[122]王桂生.自拟消癥散治疗子宫肌瘤86例[J].光明中医,2000,15(3)：43-44
[123]许树宇.浅谈子宫肌瘤的辨证论治[J].中外医疗,2008(12)：111-112
[124]张晓.子宫肌瘤的病机及证治探讨[J].南京中医药大学学报,1999,15(3)：127-138
[125]魏敏.子宫肌瘤106例治疗体会[J].云南中医中药杂志,2000,21(6)：9-11
[126]郑丽.郑家本治疗子宫肌瘤经验[J].世界中医药,2007,2(5)：284
[127]纳木恒.血府逐瘀汤加味治疗子宫肌瘤15例[J].包头医学院学报,2001,17(4)：333-334
[128]石显方,傅文录.石景亮治疗子宫肌瘤的经验[J].辽宁中医杂志,2006,37(9)：1077-107
[129]辛昕,李艳慧,彭战英,等.中药穴位贴敷治疗子宫肌瘤临床观察[J].中国针灸,2006,26(2)：113-115
[130]王风岭.中医治疗子宫肌瘤30例[J].中国乡村医药杂志,2002,9(11)：21
[131]赖慧红,高山凤,邓远梅,等.蒲归丸治疗子宫肌瘤癖热型30例临床观察[J].中医杂志,2004,45(3)：201-203
[132]张娟.消癥汤治疗子宫肌瘤60例临床观察[J].黑龙江中医药,2007,24(2)：34
[133]陈涛.基于当代名医医案数据库的舌脉诊研究[D].北京中医药大学.2006年
[134]董建华,王永炎.中国现代名中医医案精华(第一版)[M].北京：北京出版社.2002年
[1]费兆馥主编.现代中医脉诊学[M].第1版.北京：人民卫生出版社,2003：162-165
[2]罗志昌,张松,杨益民.脉搏波的工程分析与临床应用[M].北京：科学出版社,2006：8-13
[3]吴锡桂,段秀芳,黄广勇.我国老年人群单纯性收缩期高血压患病率及影响因素[J].中华心血管病杂志,2003,31(6)：456-459
[4]李进,陆业新.集镇社区35岁以上居民单纯性高血压患病率及影响因素调查[J].公共卫生与预防(?)学,2007,18(3)：63
[5]卓朗,韩令才,陈娟.单纯收缩期和舒张期高血压的影响因素与防治[J].高血压志,2006,14(4)：307-309
[6]王丽娜,曹丽,张敬一.河北省成年居民收缩期和舒张期高血压危险因素分析[J].河北医药,2008,30(1)：8-11
[7]刘伟佳,陈维清.罗不凡.广州市城乡居民高血压相关影响因素分析[J].中国公共生,2007,23(1)：34-36
[8]时景璞,王海龙,李辉,等.辽宁省彰武县农村人群高血压患病率调查[J].中华流行病学杂志,2003,24：547—550.
[9]Liao D,Arnett DK,Tyroler HA,et al. Arterial stiffness and the development of hypertension: the ARIC study.Hypertension 1999,34:201-206.
[10]汪媛,姜勇,张梅,等.中国18～69岁成人脉压分布及相关因素研究[J].中华疾病控制杂志,2009,13(2)
[11]王宏宇,张维忠,龚兰生,等.高血压病大动脉扩张性与左室肥厚关系的探讨[J].中华心血管病杂志,2000：28(3)：177
[12]俞玲,浦晓东,陈慧.人群脉压与心脑血管病发病的研究[J].心血管康复医学杂志,2008,17(2)
[13]王品晓,冯湘君.脉压与冠状动脉粥样硬化的相关性研究[J].心脑血管病防治,2005,5(3)：7-8,13
[14]袁海成,鞠芳,徐迎胜.自发性脑出血病人的平均动脉压与临床预后分析[J].泰山医学院(?)报,2000,21(2)：144-145
[15]王细川,吴荣,黄颖,等.平均动脉压及舒张压升高与靶器官功能改变的关系探讨[J].福建医药(?)志,2005,27(2)：16-17
[16]张小红,徐亚宁,欧阳存.平均动脉压对高血压性脑出血预后的影响[J].江汉大学学报(医学版),2002,30(1)：34-35
[17]付国惠.平均动脉压与脑出血预后的相关性分析[J].中国实用神经疾病杂志,2007,10(6)：94-95
[18]朱建发,姚依群,谭业颖.中心动脉压的临床意义、价值与应用临床[J].军医杂志,2009,37(3)：494-497
[19]王亚丽,陈新义,王燕.中心动脉压与周围动脉压的关系研究[J].陕西医学杂志,2004,33(7)：603-604
[20]Williams B,Lacy P S,Thom S M,et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation(CAFE)study.Circulation,2006,113:1213-1225
[21]肖沪生,银浩强,章怡祎,等.274例e TRACKING参数相关性分析及影响因素探讨[J].上海医学影像,2006,15(2)：90-92
[22]程苏畅.高血压患者中心动脉压及增强指数的分布特征及其影响因素分析[D],硕士论文
[23]黄海燕,洪明玉,程李涛,等.腹膜透析患者中影响动脉反射波增强指数的因素分析[J].中国血液净化,2006,5(4)：182-184,211
[24]沈乐一,陈晓虎,李燕.影响老年人反射波增强指数的诸因素[J].中华高血压杂志,2008,16(7)：621-624
[25]Wilkinson I B,Prasad K,HallI R,etal.Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia[J].J Am Coll Cardiol,2002,39(6):1005-1011
[26]Weber T,Auer J,O'Rourke M F,eta 1. Arterial stiffness wave reflections and the risk of coronary artery disease[J].Circulation,2004,109:184—189.
[27]Wilkinson I B,MacCallum H,Rooijmans D F,etal.Increased augmentation index and systolic stress in typel diabetes mellitus[J].QJM,2000,93(7):441-448
[1]李绍芝,颜文明.心输出量与脉图参数的相关性初探[J].中国医药学报,1992,7(2)：18-19
[2]郑建琼,林存成,王佐.子宫肌瘤患者雌激素水平和心理状况的相关性分析[J].现代中西医结合杂志,2007,16(32)：4759-4760
[3]Bakas P, Liapis A,Vlahopoulos S, et al. Estrogen receptor alpha and beta in uterine fibroids:a basis for altered estrogen responsiveness[J].Fertility and Sterility,2008,90(5):1878-1885
[4]Shozu M,Murakami K, Inoue M. Aromatase and leiomyoom of the uterus[J].Semin Reprod Med,2004,22(1):51-60.
[5]Miura S,Tanaka E,Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women[J].Maturitas,2003,45(4):293
[6]Sumino H,Ichikawa S,Kasama S,et al. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women[J].Atherosclerosis,2006,189(2):436-442
[1]王琦.中医体质学[M].北京：人民卫生出版社,2008.452466
[2]薛辉.子宫肌瘤易感体质的相关性研究[D].硕士论文
[3]司富春,李山霞.近30年临床子宫肌瘤中医证型和用药规律分析[J].世界中西医结合杂志,2009,4(1)：45-47,49
[4]明·张景岳.景岳全书[M].太原：山西科学技术出版社,2006：49
[5]韩丽华,王振涛,牛晓亚,等.充血性心衰阳虚证与免疫功能及血流变的关系[J].河南中 医,1996,16(6)：344-346
[6]姚晓天,胡炜,程志清.高血压病影响因素与中医体质类型相关性研究[J].中医学刊,2004,22(12)：2314-2316
[7]林谦,陈焱,金法,等.371例原发性高血压患者的中医体质辨证研究[J].现代中医药.2004,3(3)：17-18
[2]刘秋梅,李荣,马娉,等.5910例已婚育龄妇女妇科普查及分析[J].当代医学,2008,(14)：48-49
[3]乐杰主编.妇产科学.(第四版)[M].北京：人民卫生出版社,1980.1：98-100
[4]罗元恺主编.中医妇科学.(第五版)[M].上海：上海科学技术出版社,1985.2：382-384
[5]马宝璋主编.中医妇科学(第六版)[M].上海：上海科技出版社,1997.6：217-220
[6]张玉珍.中医妇科学(第七版)[M].北京：中国中医药出版社,2002：309-312
[7]中华人民共和国卫生部.中药新药临床研究指导原则,1993,272-273.
[8]王娜梅,崔琳.马春芬教授治疗子宫肌瘤经验[J].中医研究,2007,20(2)：56-57
[9]张珍,梁如碧.加味桂枝茯苓丸治疗子宫肌瘤62例[J].陕西中医,2008,29(3)：273-274
[10]刘弘,经燕.辨证与辨病治疗子宫肌瘤[J].中日友好医院学报,2002,16(5-6)：349-350
[11]张玲.桂苓丸治疗子宫肌瘤60例[J].实用中医药杂志,2002,18(6)：18-19
[12]袁升平.逍遥散治验举偶[J].遵义医学院学报,2002,25(1)：75-77
[13]朱丽红,李世梅,邵文彬.杨家林教授论治子宫肌瘤的学术思想[J].中医研究,2002,15(1)：6-8
[14]齐聪钱,张勤华,黄宗瀚.补肾活血方治疗子宫肌瘤63例临床观察[J].四川中医,2003,21(5)：45-46
[15]李永琼.逍遥散加味治疗子宫肌瘤78例[J].四川中医,2003,21(12)：57
[16]马庆璋.桂枝茯苓丸加味治验3则[J].陕西中医,2003,24(5)：465
[17]张世友.经方治疗疑难病验案举隅[J].中国医药学报,2003,18(12)：735-736
[18]缪雪影.姬瘤散治疗子宫肌瘤280例[J].福建中医药,2003,34(6)：7-8
[19]郑楚云,钟启良.大黄蜇虫丸加味治疗子宫肌瘤60例[J].广西中医药,2003,26(5)：33
[20]李颖,秦淑芳,王丽娜.丹七化癥胶囊治疗子宫肌瘤临床观察[J].河南中医学院学报,2003,(3)：39-40
[21]吴文菊.紫草消瘤断经汤治疗围绝经期子宫肌瘤52例[J].浙江临床医学,2003,5(9)：687
[22]吴雪华.卵巢囊肿与子宫肌瘤治验[J].山西中医,2003,19(5)：56
[23]李冬华,何裕民.子宫肌瘤患者的证候分布规律研究[J].上海中医药大学学报,2003,17(2)：30-33
[24]马哲,段俊成,王丽芳.龙血竭胶囊治疗子宫肌瘤36例临床观察[J].临床医药实践杂志,2003,12(5)：376
[25]黄元英.子宫肌瘤中西药物治疗的研究现状及展望.[J].天津中医药,2003.12,20(6)：78-80
[26]李灵芝,李桂华,陈萍.散结消瘤汤治疗子宫肌瘤临床疗效观察[J].天津中医药,2003,20(5)：22-23
[27]姜萍,赵莹,阮跃龙,等.中西医结合治疗子宫肌瘤70例疗效观察[J].现代中西医结合杂志,2003,12(7)：707-708
[28]姜永,谢平生.中医药治疗子宫肌瘤186例[J].中国中医药信息杂志,2003,10(1)：44
[29]王刘英.桂枝茯苓胶囊治疗子宫肌瘤70例疗效观察[J].云南中医中药杂志,2003,24(2)：27
[30]马文侠,李翠萍.消瘤汤治疗子宫肌瘤42例[J].中医研究,2003,16(4)：43-44
[31]罗凌,朱亚萍.清宫瘤胶囊治疗子宫肌瘤110例[J].中国中医药科技,2003,10(6)：382-383
[32]孙淑芳,周琦,孙淑芳,等.中药内服外用治疗子宫肌瘤105例[J].贵州医药,2003,27(9)：862
[33]严英,周伟生,余琦.子宫肌瘤的中医治疗概况[J].新中医,2003,35(12)：62-64
[34]桑海莉.行气活血_软坚散结法治疗子宫肌瘤的临床与实验研究[J].中医杂志,2003,44(1)：41-43
[35]孙运美.自拟清宫化瘤散治疗子宫肌瘤20例疗效观察[J].现代中西医结合杂志,2004,13(2)：212
[36]盛晓波,赵强.牡蛎莪术汤治疗子宫肌瘤46例[J].浙江中医杂志2004,(3)：113
[37]王其蓉,魏书德.桂枝茯苓汤治疗子宫肌瘤13例[J].实用中医药杂志,2004,20(3)：124
[38]王燕兰.中西医结合治疗围绝经期子宫肌瘤64例疗效观察[J].吉林中医药,2004,25(1)：38-39
[39]戎海仁,于岗.活血化瘀法治疗妇科病拾零[J].河北中医,2004,26(3)：191-192
[40]高民.浅谈补气理气、活血化瘀治疗气滞血瘀型卵巢囊肿、子宫肌瘤的体会[J].黑龙江中医 药,2004,(2)：34-45
[41]曾菲英,刘文.肖承惊教授治疗子宫肌瘤经验述要[J].中医药学刊,2004,22(4)：587-588
[42]王福娟.桂枝茯苓丸临床应用[J].医案医话,2008,28(4)：290
[43]曾菲英.益气缩宫法治疗子宫肌瘤异常出血经验[J].北京中医药大学学报,2004,27(3)：91-92
[44]黄晓君.桂枝茯苓丸加味验案举隅[J].陕西中医,2004(5)：459-460
[45]邓德强,马骏.马德孚教授治疗癥瘕经验[J].河北中医,2004,26(4)：248-249
[46]王艳霞,赵友林.中药内服加灌肠治疗子宫肌瘤[J].实用中医内科杂志,2004,18(3)：258-259
[47]臧金霞.妇科化瘀胶囊临床使用总结报告[J].中医中药,2007,4(1)：115-116
[48]古春青.少腹逐瘀汤合大黄蛰虫丸加减治疗子宫肌瘤89例疗效观察[J].中医临床选萃,2007,23(22)：51
[49]王泽民,杜艳林,王婧.中医药治疗子宫肌瘤的进展[J].北京中医,2007,26(11)：752-754
[50]马露玲.消症汤保留灌肠治疗子宫肌瘤42例临床观察[J].临床医药实践杂志,2007,16(11)：1092-1093
[51]许雁.中西药联合治疗子宫肌瘤的效果观察[J].临床误诊误治,2007,20(7)：60-61
[52]钱麟,齐聪,张勤华.补肾消瘤方治疗80例子宫肌瘤临床疗效分析[J].实用诊断与治疗杂志,2007,21(8)：574-576
[53]马娴,傅萍.傅萍治疗子宫肌瘤临床经验[J].辽宁中医药大学学报,2007,9(5)：84-85
[54]刘向阳.胥受天老中医治疗子宫肌瘤经验简介[J].陕西中医,2001,22(6)：353
[55]肖笃凯.桂枝茯苓胶囊治疗子宫肌瘤308例疗效情况分析[J].中西医结合与祖国医学,2007,11(9)：793-794
[56]吕美.益气化瘀消瘤汤治疗子宫肌瘤60例临床观察[J].山东中医杂志,2007,26(9)：604-606
[57]张秋梅,陈旭,孙增玉,等.中药袁氏消瘤汤治疗子宫肌瘤临床观察[J].辽宁中医杂志,2007,34(9)：1272-1273
[58]招泽熙.中医辨证治疗子宫肌瘤39例[J].湖南中医药导报,1999,2(6)：13-14.
[59]李文红.中医辨证治疗子宫肌瘤38例[J].河北中医,2001,23(5)：337-338
[60]李天海,李橘梅,李瑞阳,等.子宫肌瘤的辨证分型治疗[J].河北中医,1999,20(5)：291-292.
[61]付静.桂枝茯苓丸化裁临床应用举隅[J].中国民间疗法,2007,15(7)：30-31
[62]孙永忠,金方.大黄牡丹汤妇科应用举隅[J].江西中医药,2007,38(6)：59
[63]马建军.自拟蛎甲散消汤治疗子宫肌瘤108例[J].实用中医内科杂志,2007,21(3)：40-41
[64]王佳禾.化癥丹治疗子宫肌瘤的临床研究[J].辽宁中医杂志,2007,34(6)：782-783
[65]黄丽慧.子宫肌瘤的中医药治疗近况[J].河北中医,2007,29(4)：363-365
[66]彭丽娜.疏肝消癥汤治疗子宫肌瘤50例临床体会[J].医疗保健器具,2007,(4)：13-14
[67]李晋先,张慧珍.中西医结合治疗子宫肌瘤疗效观察[J].长治医学院学报,2006,(4)：300-301
[68]张铁.血府逐瘀汤治疗血瘀气滞型子宫肌瘤的理论探析[J].中医药学刊,2006,24(10)：1928-1929
[69]张登山.王云铭辨治妇科症瘕经验[J].安徽中医学院学报,2006,25(4)：23-24
[70]武步涛.武明钦临床验案3则[J].河南中医,2006,26(8)：75
[71]杨玉杰.桃红四物汤加减治疗妇科病2例[J].辽宁中医杂志,2006,33(7)：863
[72]刘宪鸣.自拟消癥汤治疗子宫肌瘤53例[J].中国中医药科技,2006,13(2)：134-135
[73]高淑梅,刘会怡.益气活血法治疗子宫肌瘤40例疗效观察[J].实用中医内科杂志,2006,20(2)：190-191
[74]肖新春,傅金英.消瘋勿忘扶正[J].中医药学刊,2006,24(3)：492
[75]张秉芬,裴利红.自拟消瘤汤治疗子宫肌瘤80例[J].齐鲁护理杂志,2006,12(1)：83
[76]陆耘,邓志红.化癥汤治疗气滞血瘀证子宫肌瘤临床观察[J].安徽中医学院学报2005,24(6)：16-17
[77]安峥嵘.宫瘤汤治疗子宫肌瘤43例[J].现代中医药,2005,25(6)：30
[78]李祥云.中医妇科肿瘤的研究概况—李祥云教授妇科系列经验[J].辽宁中医杂志,2005,32(7)：636-638
[79]张健.化淤消癥汤治疗子宫肌瘤100例临床报告[J].中国自然医学杂志,2005,7(1)：71-72
[80]刘兴明.抵挡汤加味治疗子宫肌瘤28例[J].现代医药卫生,2005,21(9)：1118-1119
[81]孔洁,黄宝光.消肌汤治疗子宫肌瘤32例临床观察[J].吉林中医药,2005,25(1)：25
[82]肖颖,黄绳武.中药治疗子宫肌瘤的现代研究概况[J].广东医药,2005,15(1)：52-54
[83]张策.子宫肌瘤辨治心得[J].江苏中医药2005,(26)：22-23
[84]蒋薇.龙骨、牡蛎在妇科疾病中的应用[J].河北中医,2005,27(1)：34-35
[85]李凤军.中西医结合序贯治疗子宫肌瘤160例[J].河南中医,2005,25(1)：59-60
[86]冯泽芳.活血化滞消瘤汤内外兼治子宫肌瘤98例[J].四川中医,2005,23(2)：67
[87]李祥云.中医辨证与实验检查的研究—李祥云教授妇科系列经验[J].辽宁中医杂志,2005,32(1)：7-8
[88]林红.桂枝茯苓胶囊治疗妇科疾病临床效果分析[J].中国基层医药,2004,11(12)：1509
[89]王淑英.桂枝茯苓丸加味治疗妇人癥积[J].张家口医学院学报,2004,21(1)：67
[90]齐南,马彦超,周志刚.石瘕症治疗探讨[J].陕西中医学院学报,2004,27(6)：48-49
[91]杨会华.自拟方剂宫外孕Ⅱ号加减治疗子宫肌瘤60例[J].社区医学杂志,2004,2(1)：59-60
[92]吴阳平.消癥汤的临床应用[J].福建中医药,2004,35(5)：55
[93]刁莉.桂枝茯苓丸加味治疗子宫肌瘤[J].中国冶金工业医学杂志,2004,21(4)：317-318
[94]张志明,彭瑛.丁玉珠治疗疑难杂病举隅[J].内蒙古中医药,2002,(6)：15
[95]叶腾辉,陈敬康.宫瘤消胶囊治疗子宫肌瘤病60例[J].四川中医,2002,20(1)：53-54
[96]王玲,周益法.海藻玉壶汤临证举隅[J].深圳中西医结合杂志,1999,9(4)：46-47
[97]刘向阳.胥受天老中医治子宫肌瘤经验简介[J].陕西中医,2001,22(6)：353
[98]麦顺辉.子宫肌瘤86例中医辨证施治体会[J].广东医学,1999,20(3)：226
[99]韩惠兰,于飞.子宫肌瘤的中医治疗[J].中国实用妇科与产科杂志,2001,17(3)：135-136
[100]张新荣.当归芍药散合桂枝茯苓丸的临床新用[J].深圳中西医结合杂志,2001,11(3)：157-158
[101]爨昌劳,尚何青,富延萍.定经汤治疗子宫肌瘤30例[J].陕西中医,2002,23(11)：975-976
[102]张国恒,姚晓丽.扶正祛邪治疗子宫肌瘤36例分析[J].新疆中医药,2000,18(2)：19-20
[103]田敬然,马淑华.宫瘤消治疗子宫肌瘤100例疗效观察[J].河北中医,1999,21(5)：278
[104]刘乔平,何玉宁,郭红.桂枝茯苓丸加味治疗子宫肌瘤37例临床观察[J].云南中医中药杂志,2001,22(3)：35-36
[105]吴绣虹.桂枝茯苓丸配合活血化瘀药治疗子宫肌瘤37例[J].新中医,2001,33(8)：56-57
[106]耿静.海藻玉壶汤治疗妇科杂证举隅[J].深圳中西医结合杂志,2001,11(4)：237-238
[107]于涛,曹守伟,支楠.化湿散结汤治疗子宫平滑肌瘤30例疗效观察[J].江西中医 药,2002,33(5)：23-24
[108]任晓丹.李春华治疗子宫肌瘤经验[J].辽宁中医学院学报,2002,4(4)：291-292
[109]李云端.理冲汤治妇科癥瘕验案3则[J].国医论坛,2000,15(3)：37
[110]张丽君,刘华莎.通络消瘤汤治疗子宫肌瘤36例[J].安徽中医学院学报,2002,21(3)：22-23
[111]韩建锋.脱花煎加味治疗肿瘤[J],2002,(10)：437
[112]李乃荣.肖承宗益气化瘀祛痰法治疗子宫肌瘤经验[J].安徽中医临床杂志,2001,13(6)：455-456
[113]郭喜兰.血府逐瘀汤临床应用举隅[J].陕西中医,2002,23(8)：753
[114]陈芊.杨明亮治疗子宫肌瘤经验[J].江西中医药,2000,31(6)：6-7
[115]舒珊,舒畅.中西医结合治疗子宫肌瘤30例临床观察[J].洛阳医专学报,2001,19(4)：308-309
[116]李玲,何裕民,李冬华.中药“瘤净片”治疗子宫肌瘤78例疗效观察[J].上海中医药杂志,2000,(11)：24-25
[117]牛玉香.中医辨证施治子宫肌瘤20例报告[J].济宁医学院学报,1999,(2)：60
[118]那天佑,杨钟娣.子宫肌瘤106例治疗体会[J].云南中医中药杂志,2000,21(6)：9-11
[119]张晓.子宫肌瘤的病机及证治探讨[J].南京中医药大学学报,1999,15(3)：137-138
[120]杨家林.子宫肌瘤的中医治疗[J].实用妇产科杂志,1999,15(2)：66-67
[121]张成秀.自拟三山消癥汤治疗子宫肌瘤67例报告[J].甘肃中医,2002,15(3)：53
[122]王桂生.自拟消癥散治疗子宫肌瘤86例[J].光明中医,2000,15(3)：43-44
[123]许树宇.浅谈子宫肌瘤的辨证论治[J].中外医疗,2008(12)：111-112
[124]张晓.子宫肌瘤的病机及证治探讨[J].南京中医药大学学报,1999,15(3)：127-138
[125]魏敏.子宫肌瘤106例治疗体会[J].云南中医中药杂志,2000,21(6)：9-11
[126]郑丽.郑家本治疗子宫肌瘤经验[J].世界中医药,2007,2(5)：284
[127]纳木恒.血府逐瘀汤加味治疗子宫肌瘤15例[J].包头医学院学报,2001,17(4)：333-334
[128]石显方,傅文录.石景亮治疗子宫肌瘤的经验[J].辽宁中医杂志,2006,37(9)：1077-107
[129]辛昕,李艳慧,彭战英,等.中药穴位贴敷治疗子宫肌瘤临床观察[J].中国针灸,2006,26(2)：113-115
[130]王风岭.中医治疗子宫肌瘤30例[J].中国乡村医药杂志,2002,9(11)：21
[131]赖慧红,高山凤,邓远梅,等.蒲归丸治疗子宫肌瘤癖热型30例临床观察[J].中医杂志,2004,45(3)：201-203
[132]张娟.消癥汤治疗子宫肌瘤60例临床观察[J].黑龙江中医药,2007,24(2)：34
[133]陈涛.基于当代名医医案数据库的舌脉诊研究[D].北京中医药大学.2006年
[134]董建华,王永炎.中国现代名中医医案精华(第一版)[M].北京：北京出版社.2002年
[1]费兆馥主编.现代中医脉诊学[M].第1版.北京：人民卫生出版社,2003：162-165
[2]罗志昌,张松,杨益民.脉搏波的工程分析与临床应用[M].北京：科学出版社,2006：8-13
[3]吴锡桂,段秀芳,黄广勇.我国老年人群单纯性收缩期高血压患病率及影响因素[J].中华心血管病杂志,2003,31(6)：456-459
[4]李进,陆业新.集镇社区35岁以上居民单纯性高血压患病率及影响因素调查[J].公共卫生与预防(?)学,2007,18(3)：63
[5]卓朗,韩令才,陈娟.单纯收缩期和舒张期高血压的影响因素与防治[J].高血压志,2006,14(4)：307-309
[6]王丽娜,曹丽,张敬一.河北省成年居民收缩期和舒张期高血压危险因素分析[J].河北医药,2008,30(1)：8-11
[7]刘伟佳,陈维清.罗不凡.广州市城乡居民高血压相关影响因素分析[J].中国公共生,2007,23(1)：34-36
[8]时景璞,王海龙,李辉,等.辽宁省彰武县农村人群高血压患病率调查[J].中华流行病学杂志,2003,24：547—550.
[9]Liao D,Arnett DK,Tyroler HA,et al. Arterial stiffness and the development of hypertension: the ARIC study.Hypertension 1999,34:201-206.
[10]汪媛,姜勇,张梅,等.中国18～69岁成人脉压分布及相关因素研究[J].中华疾病控制杂志,2009,13(2)
[11]王宏宇,张维忠,龚兰生,等.高血压病大动脉扩张性与左室肥厚关系的探讨[J].中华心血管病杂志,2000：28(3)：177
[12]俞玲,浦晓东,陈慧.人群脉压与心脑血管病发病的研究[J].心血管康复医学杂志,2008,17(2)
[13]王品晓,冯湘君.脉压与冠状动脉粥样硬化的相关性研究[J].心脑血管病防治,2005,5(3)：7-8,13
[14]袁海成,鞠芳,徐迎胜.自发性脑出血病人的平均动脉压与临床预后分析[J].泰山医学院(?)报,2000,21(2)：144-145
[15]王细川,吴荣,黄颖,等.平均动脉压及舒张压升高与靶器官功能改变的关系探讨[J].福建医药(?)志,2005,27(2)：16-17
[16]张小红,徐亚宁,欧阳存.平均动脉压对高血压性脑出血预后的影响[J].江汉大学学报(医学版),2002,30(1)：34-35
[17]付国惠.平均动脉压与脑出血预后的相关性分析[J].中国实用神经疾病杂志,2007,10(6)：94-95
[18]朱建发,姚依群,谭业颖.中心动脉压的临床意义、价值与应用临床[J].军医杂志,2009,37(3)：494-497
[19]王亚丽,陈新义,王燕.中心动脉压与周围动脉压的关系研究[J].陕西医学杂志,2004,33(7)：603-604
[20]Williams B,Lacy P S,Thom S M,et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation(CAFE)study.Circulation,2006,113:1213-1225
[21]肖沪生,银浩强,章怡祎,等.274例e TRACKING参数相关性分析及影响因素探讨[J].上海医学影像,2006,15(2)：90-92
[22]程苏畅.高血压患者中心动脉压及增强指数的分布特征及其影响因素分析[D],硕士论文
[23]黄海燕,洪明玉,程李涛,等.腹膜透析患者中影响动脉反射波增强指数的因素分析[J].中国血液净化,2006,5(4)：182-184,211
[24]沈乐一,陈晓虎,李燕.影响老年人反射波增强指数的诸因素[J].中华高血压杂志,2008,16(7)：621-624
[25]Wilkinson I B,Prasad K,HallI R,etal.Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia[J].J Am Coll Cardiol,2002,39(6):1005-1011
[26]Weber T,Auer J,O'Rourke M F,eta 1. Arterial stiffness wave reflections and the risk of coronary artery disease[J].Circulation,2004,109:184—189.
[27]Wilkinson I B,MacCallum H,Rooijmans D F,etal.Increased augmentation index and systolic stress in typel diabetes mellitus[J].QJM,2000,93(7):441-448
[1]李绍芝,颜文明.心输出量与脉图参数的相关性初探[J].中国医药学报,1992,7(2)：18-19
[2]郑建琼,林存成,王佐.子宫肌瘤患者雌激素水平和心理状况的相关性分析[J].现代中西医结合杂志,2007,16(32)：4759-4760
[3]Bakas P, Liapis A,Vlahopoulos S, et al. Estrogen receptor alpha and beta in uterine fibroids:a basis for altered estrogen responsiveness[J].Fertility and Sterility,2008,90(5):1878-1885
[4]Shozu M,Murakami K, Inoue M. Aromatase and leiomyoom of the uterus[J].Semin Reprod Med,2004,22(1):51-60.
[5]Miura S,Tanaka E,Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women[J].Maturitas,2003,45(4):293
[6]Sumino H,Ichikawa S,Kasama S,et al. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women[J].Atherosclerosis,2006,189(2):436-442
[1]王琦.中医体质学[M].北京：人民卫生出版社,2008.452466
[2]薛辉.子宫肌瘤易感体质的相关性研究[D].硕士论文
[3]司富春,李山霞.近30年临床子宫肌瘤中医证型和用药规律分析[J].世界中西医结合杂志,2009,4(1)：45-47,49
[4]明·张景岳.景岳全书[M].太原：山西科学技术出版社,2006：49
[5]韩丽华,王振涛,牛晓亚,等.充血性心衰阳虚证与免疫功能及血流变的关系[J].河南中 医,1996,16(6)：344-346
[6]姚晓天,胡炜,程志清.高血压病影响因素与中医体质类型相关性研究[J].中医学刊,2004,22(12)：2314-2316
[7]林谦,陈焱,金法,等.371例原发性高血压患者的中医体质辨证研究[J].现代中医药.2004,3(3)：17-18